Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
Director
-
Issuer Symbol
-
SABS, SABSW on Nasdaq
There are no Buy or Sell transactions made by Sessa Capital (Master), L.P. since 07 Mar 2025
Holdings reported by Sessa Capital (Master), L.P. for SAB Biotherapeutics, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
2,198,457 |
$3,847,299 |
$1.75 |
29 Sep 2025 |
Direct |
|
|
| Series B Convertible Preferred Stock |
211,100 |
|
|
29 Sep 2025 |
Direct |
Common Stock |
|
| Warrants (right to buy) |
114,250 |
|
|
22 Jul 2025 |
Direct |
Series B Convertible Preferred Stock |
|
Transactions reported by Sessa Capital (Master), L.P. for SAB Biotherapeutics, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.